Episode Library: References and Guests
Episode #1: Postoperative Chemotherapy for Rectal Cancer (October 2016)
In the first ever episode of the podcast, the Dana-Farber/Brigham and Women's presents a discussion between Dr. Ronald Bleday and his colleague, Dr. Marios Giannakis. They discuss a rectal cancer case involving the use of chemotherapy after surgery and radiation.
Ep. 1 References:
- Bujko K, Glimelius B, Valentini V, Michalski W, Spalek M. Postoperative chemotherapy in patients with rectal cancer receiving preoperative radio(chemo)therapy: A meta-analysis of randomized trials comparing surgery ± a fluoropyrimidine and surgery + a fluoropyrimidine ± oxaliplatin. Eur J Surg Oncol. 2015 Jun;41(6):713-23.
- Maas M, Nelemans PJ, Valentini V, Crane CH, Capirci C, Rödel C, Nash GM, Kuo LJ, Glynne-Jones R, García-Aguilar J, Suárez J, Calvo FA, Pucciarelli S, Biondo S,Theodoropoulos G, Lambregts DM, Beets-Tan RG, Beets GL. Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection: a pooled analysis of 3,313 patients. Int J Cancer. 2015 Jul 1;137(1):212-20.
Episode #2: Rectal Cancer Imaging (October 2016)Dr. Michael Rosenthal shares a case with the team, and discussed the optimal imaging methods for rectal cancer staging and decision making.
Ep. 2 References:
- Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis. Radiology 2004;232:773-83.
- Hartman RI, Chang CY, Wo JY, et al. Optimizing adjuvant treatment decisions for stage t2 rectal cancer based on mesorectal node size: a decision analysis. Academic radiology 2013;20:79-89.
Episode #3: Colorectal Cancer and Inflammatory Bowel Disease (November 2016)
This episode's guests are Dr. Joshua Korzenik and Dr. Harvey Mamon. Both doctors join Dr. Ronald Bleday for a discussion about a patient with colitis who developed an upper rectal cancer. Abstract and more info on this article can be found by clicking here.
Ep. 3 References:
- White EC1, Murphy JD, Chang DT, Koong AC: Low Toxicity in Inflammatory Bowel Disease Patients Treated With Abdominal and Pelvic Radiation Therapy. Am J Clin Oncol. 2015 Dec; 38 (6): 564-9.
Episode #4: Frailty during Colorectal Cancer Care (December 2016)
Episode #5: Colorectal Cancer Genetics, Microsatellite Instability, and Checkpoint Inhibitors (January 2017)
Ron and Jeff discuss their care of a recent colorectal cancer patient with Lynch Syndrome. The episode explores the case's complications, immunotherapy, genetics, and steps in the treatment process when handling this type of case.
In this episode, our hosts talk over a case with two specialists in immunotherapy from the Dana-Farber: Dr. Osama Rahma and Dr. Matthew Yurgelun. After reviewing the patient and case details, our guests outline the unique set of challenges during treatment due to the patient testing positive for Lynch Syndrome. It is an engaging discussion.
The How We Treat Colon & Rectal Cancer podcast's next two episodes will feature discussions about clinical trials focused on colorectal cancer treatment. In part one, Dr. Deborah Schrag joins us to provide an inside look at the PROSPECT trial currently taking place.
PROSPECT is the acronym for Preoperative Radiation Or Selective Preoperative Radiation and Evaluation before Chemotherapy and Total Mesorectal Excision (TME). From the on-going trial, Dr. Schrag and her team hope to decipher and compare the results of standard chemo and radiation treatment using a regimen of drugs named FOLFOX (the drugs 5-fluorouracil (5-FU), oxaliplatin and leucovorin). To learn more about this trial, listeners can click here.
Episode #7: Clinical and Surgical Trials [Pt. 2] (March 2017)
In the second part of our discussion on colorectal cancer trials, Dr. James Fleshman joins Ron to discuss the ACOSOG Z6051 Randomized Clinical Trial. This surgical trial aims to decipher the differences of open versus laparoscopic surgery in the treatment of colorectal cancer. To read more about Dr. Fleshman's findings and reports click here.
Dr. Fleshman is the Helen and Stanley Joseph Seeger Professor and Chairman, Department of Surgery at Baylor University Medical Center in Dallas. His professional focus is the treatment of patients with colorectal diseases. He has developed an international reputation in the laparoscopic treatment of colorectal cancer and the development of randomized controlled trials to evaluate the use of laparoscopic techniques in the treatment of colorectal cancer. Click here to read a full bio.
In this episode, Jeff and Ron also answer a listener question and discuss the future of patient trials in this field.